TY - JOUR
T1 - Once we have it, will we use it?
T2 - A European survey on willingness to be vaccinated against COVID-19
AU - Neumann-Böhme, Sebastian
AU - Varghese, Nirosha Elsem
AU - Sabat, Iryna
AU - Barros, Pedro P.
AU - Brouwer, Werner B F
AU - van Exel, Job
AU - Schreyögg, Jonas
AU - Stargardt, Tom
N1 - Funding text: European Union (EU) grant nr. 721402; Excellence Strategy by the German federal and state governments; University of Hamburg, Erasmus School of Health Policy Management; Nova School of Business and Economics Lisbon-Chair BPI | "Fundacao La Caixa" on Health Economics
PY - 2020/9/1
Y1 - 2020/9/1
N2 - While the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect against the disease COVID-19, policymakers should prepare for the next challenge: uptake of the vaccine among the public. Having a vaccine does not automatically imply it will be used. Compliance with the anti-H1N1 vaccine during the 2009 influenza pandemic, for instance, was low [1], and in the decade since, vaccination rates have remained an issue of concern [2] while vaccination hesitancy has become more prevalent, leading to increases in disease outbreaks in multiple countries [3]. It is, therefore, important to understand whether or not people are willing to be vaccinated against COVID-19, as this can have large consequences for the success a vaccination programme—with potentially large health and economic consequences. In this editorial, we provide some first insights into this willingness to be vaccinated, based on a multi-country European study [4], which hopefully result in more attention for this important issue.
AB - While the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect against the disease COVID-19, policymakers should prepare for the next challenge: uptake of the vaccine among the public. Having a vaccine does not automatically imply it will be used. Compliance with the anti-H1N1 vaccine during the 2009 influenza pandemic, for instance, was low [1], and in the decade since, vaccination rates have remained an issue of concern [2] while vaccination hesitancy has become more prevalent, leading to increases in disease outbreaks in multiple countries [3]. It is, therefore, important to understand whether or not people are willing to be vaccinated against COVID-19, as this can have large consequences for the success a vaccination programme—with potentially large health and economic consequences. In this editorial, we provide some first insights into this willingness to be vaccinated, based on a multi-country European study [4], which hopefully result in more attention for this important issue.
UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85087309916&origin=resultslist&sort
U2 - 10.1007/s10198-020-01208-6
DO - 10.1007/s10198-020-01208-6
M3 - Article
C2 - 32591957
SN - 1618-7598
VL - 21
SP - 977
EP - 982
JO - European Journal Of Health Economics
JF - European Journal Of Health Economics
IS - 7
ER -